Skip to main content

Cannon Financial Strategists, Inc.

Position in TTRX — Turn Therapeutics Inc.

CIK 2031123 ATHENS, GA

Position in TTRX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$73,000
New position
Shares Held
10,000
first reported quarter
Ownership
0.034%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#24
of 29 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cannon Financial Strategists, Inc. holds $1,183,300 across 2 Biotechnology names. TTRX ranks #2 (6.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 TTRX
Turn Therapeutics Inc.
This page
10,000 $73,000

All Filings in TTRX

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $73,000 10,000